These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 36175504)

  • 1. m6A RNA methylation regulator-related signatures exhibit good prognosis prediction ability for head and neck squamous cell carcinoma.
    Zhai Y; Zheng L
    Sci Rep; 2022 Sep; 12(1):16358. PubMed ID: 36175504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Signature of N
    Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
    Front Immunol; 2022; 13():809872. PubMed ID: 35185897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of a novel risk model based on cuproptosis‑associated m6A for head and neck squamous cell carcinoma.
    Xing Z; Xu Y; Xu X; Yang K; Qin S; Jiao Y; Wang L
    BMC Med Genomics; 2024 May; 17(1):137. PubMed ID: 38778403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
    Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
    Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The methylation modification of m6A regulators contributes to the prognosis of head and neck squamous cell carcinoma.
    Chen Y; Jiang X; Li X; Yan D; Liu J; Yang J; Yan S
    Ann Transl Med; 2021 Aug; 9(16):1346. PubMed ID: 34532483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of an m6A-related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma.
    Zhou C; Wang S; Shen Z; Shen Y; Li Q; Shen Y; Huang J; Deng H; Ye D; Zhan G; Li J
    J Clin Lab Anal; 2022 Jan; 36(1):e24113. PubMed ID: 34783061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An angiogenesis-associated gene-based signature predicting prognosis and immunotherapy efficacy of head and neck squamous cell carcinoma patients.
    Chen B; Han Y; Sheng S; Deng J; Vasquez E; Yau V; Meng M; Sun C; Wang T; Wang Y; Sheng M; Wu T; Wang X; Liu Y; Lin N; Zhang L; Shao W
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):91. PubMed ID: 38347320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma.
    Huang J; Xu Z; Teh BM; Zhou C; Yuan Z; Shi Y; Shen Y
    J Clin Lab Anal; 2022 Jun; 36(6):e24480. PubMed ID: 35522142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of RNA Modification-Associated Alternative Splicing Signature as an Independent Factor in Head and Neck Squamous Cell Carcinoma.
    Liu J; Deng W; Xiao Z; Huang X; Lin M; Long Z
    J Immunol Res; 2022; 2022():8976179. PubMed ID: 36157883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory response-related genes predict prognosis in patients with HNSCC.
    Jing SL; Afshari K; Guo ZC
    Immunol Lett; 2023 Jul; 259():46-60. PubMed ID: 37279805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma.
    Li Z; Shen L; Li Y; Shen L; Li N
    Cancer Med; 2022 Dec; 11(24):5129-5144. PubMed ID: 35574984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A predictive model of immune infiltration and prognosis of head and neck squamous cell carcinoma based on cell adhesion-related genes: including molecular biological validation.
    Liu Y; Wu Z; Fu Z; Han Y; Wang J; Zhang Y; Liang B; Tao Y; Zhang Y; Shen C; Xu Y; Yin S; Chen B; Liu Y; Pan H; Liang Z; Wu K
    Front Immunol; 2023; 14():1190678. PubMed ID: 37691922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pyroptosis-related gene expression signature predicts immune microenvironment and prognosis in head and neck squamous cell carcinoma.
    Zhou W; Feng M; Qi F; Qiao J; Fan L; Zhang L; Hu X; Huang C
    Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):953-963. PubMed ID: 38063904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.
    Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q
    BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a m
    Zhao X; Cui L
    Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.
    Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J
    BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.